Chimeric antigen receptor (CAR) T treatmentsvaccinescheckpoint blockadeGlioblastomaGBM
…ines, showed safety and immunogenicity but no survival benefit. Chimeric antigen receptor (CAR) T treatments in GBM trials have yielded feasibility and antitumor signals bu…